首页 > 最新文献

Journal of Research in Ayurvedic Sciences最新文献

英文 中文
World Herbal Encyclopedia 世界草药百科全书
Pub Date : 2023-04-01 DOI: 10.4103/jras.jras_107_23
A. Balkrishna
{"title":"World Herbal Encyclopedia","authors":"A. Balkrishna","doi":"10.4103/jras.jras_107_23","DOIUrl":"https://doi.org/10.4103/jras.jras_107_23","url":null,"abstract":"","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"174 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123204468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Powering the Growth of India’s Ayush Sector 推动印度阿尤什行业的增长
Pub Date : 2023-04-01 DOI: 10.4103/jras.jras_102_23
Indroneel Das, Krutika K. Mehra, V. Reddy, Eeshana Ish, Ramayi Kayina
The vision, foresight and guidance of the Hon’ble Prime Minister, proxied strongly by the mentions of the Ayush sector and the Ministry of Ayush in ‘Mann Ki Baat’ have coincided with the rapid growth & development of the Ayush sector in India, and its increased demand across the globe. The two are hypothesized to have coincided because of a potential direct correlation between the impact and credibility of the Hon’ble Prime Minister’s highlights of Ayush through ‘Mann Ki Baat’, which have translated into a metamorphosis of the sector as a multiplier effect of the number of people & institutions following the commentary of ‘Mann Ki Baat’, as well as the credibility & coverage of ‘Mann Ki Baat’. The growth seen in Ayush industry (manufacturing & services), research & development, public health initiatives & demand, global traction, investment interest, and regulatory frameworks strongly support this correlation, especially when seen considering the specific initiatives, events, and developments of the Ayush sector which have been highlighted in a particular timeline by the Hon’ble PM, show a parallel upsurge in that specific (or related) sub-sector of Ayush. The objective of the current study is to Analyze & establish the impact of Ayush related highlights & mentions of the Hon’ble Prime Minister on ‘Mann Ki Baat’, on the Ayush sector. In the current work the Objective analysis of ongoing initiatives, events of Ministry of Ayush, supported by Ayush Strategic Policy & Facilitation Bureau (Invest India). Knowledge derived from/data sourced from the following: 1. Ayush Strategic Policy & Facilitation Bureau (Invest India) knowledge sources & investigations 2. Ayush Strategic Policy & Facilitation Bureau (Invest India) industry interaction & feedback 3. Internal assessments & data from Ministry of Ayush 4. Startup India/Department for Promotion of Industry &Internal Trade databases 5. RIS Report on “Ayush Sector in India: Prospects & Challenges” 6. RIS Report on “Ayush Exports: Regulatory Opportunities & Challenges in Key Markets” 7. Invest India (Strategic Investment Research Unit) Report on “Think Holistic Health, Think India” 8. All India Institute of Ayurveda knowledge sourcesObservations and developments captured from the above have been juxtaposed thematically with domain-specific announcements by Hon’ble Prime Minister through ‘Mann Ki Baat’ and impacts have been studied in short-term (between 6 months to 1 year of announcement/attention given to a particular theme in Ayush) and sustainable long-term trends that have henceforth developed in the sector (as evidenced by Govt. data and ‘Mann Ki Baat’ announcements, from 2014 to 2023)Evidences from the listed methods &sources suggest a strong direct correlation between specific instances of Hon’ble Prime Minister’s coverage and/or mention of Ayush in ‘Mann Ki Baat’ (specific instances in Annexure 1) and a sustainable upsurge in the related domain Wof Ayush. Moreover, the overall synergistic impact o
在“Mann Ki Baat”中提到的阿尤什部门和阿尤什部强烈代表了总理的远见,远见和指导,这与印度阿尤什部门的快速增长和发展以及全球需求的增加相吻合。这两者被假设是一致的,因为总理阁下通过“Mann Ki Baat”对Ayush的强调的影响和可信度之间存在潜在的直接关联,这已经转化为该部门的蜕变,作为“Mann Ki Baat”评论之后的人员和机构数量的乘数效应,以及“Mann Ki Baat”的可信度和覆盖率。阿尤什工业(制造和服务)、研发、公共卫生倡议和需求、全球牵引力、投资兴趣和监管框架的增长有力地支持了这种相关性,特别是考虑到阿尤什行业的具体举措、事件和发展,这些都是由总理在特定时间点强调的,表明阿尤什的特定(或相关)子行业也出现了平行增长。当前研究的目的是分析和确定与阿尤什相关的亮点和提及“Mann Ki Baat”总理对阿尤什部门的影响。在目前的工作中,在阿尤什战略政策和促进局(投资印度)的支持下,对阿尤什部正在进行的倡议和事件进行客观分析。来自以下方面的知识/数据:阿尤什战略政策与促进局(印度投资)知识来源和调查阿尤什战略政策与促进局(印度投资)行业互动与反馈来自阿尤什部的内部评估和数据启动印度/促进工业和内部贸易部门数据库RIS关于“印度阿尤什行业:前景与挑战”的报告RIS报告“阿尤什出口:关键市场的监管机遇与挑战”投资印度(战略投资研究单位)关于"思考整体健康,思考印度"的报告所有印度阿育吠陀研究所知识来源从上述观察和发展中获得的主题与总理通过“Mann Ki Baat”发布的特定领域公告并列,并在短期(6个月至1年的公告/对阿尤什特定主题的关注)和可持续的长期趋势中研究了影响,这些趋势从此在该行业发展(如政府数据和“Mann Ki Baat”公告所证明的那样)。从2014年到2023年)所列出的方法和来源的证据表明,在“Mann Ki Baat”(附件1中的具体实例)中,Hon ' ble总理的报道和/或提到Ayush的具体实例与相关领域的持续高涨之间存在着强烈的直接关联。此外,“Mann Ki Baat”在2014-2023年期间的整体协同影响提供了多个数据点(接近50个),其中“Mann Ki Baat”中提到的数据点与该行业近期的积极需求和/或发展相吻合,并形成了该行业的长期趋势。因此,可以得出的结论是,总理先生通过他的愿景和对“Mann Ki Baat”的阿尤什部门的强调,已经引起并催化了阿尤什部门在国内和全球的增长。
{"title":"Powering the Growth of India’s Ayush Sector","authors":"Indroneel Das, Krutika K. Mehra, V. Reddy, Eeshana Ish, Ramayi Kayina","doi":"10.4103/jras.jras_102_23","DOIUrl":"https://doi.org/10.4103/jras.jras_102_23","url":null,"abstract":"The vision, foresight and guidance of the Hon’ble Prime Minister, proxied strongly by the mentions of the Ayush sector and the Ministry of Ayush in ‘Mann Ki Baat’ have coincided with the rapid growth & development of the Ayush sector in India, and its increased demand across the globe. The two are hypothesized to have coincided because of a potential direct correlation between the impact and credibility of the Hon’ble Prime Minister’s highlights of Ayush through ‘Mann Ki Baat’, which have translated into a metamorphosis of the sector as a multiplier effect of the number of people & institutions following the commentary of ‘Mann Ki Baat’, as well as the credibility & coverage of ‘Mann Ki Baat’. The growth seen in Ayush industry (manufacturing & services), research & development, public health initiatives & demand, global traction, investment interest, and regulatory frameworks strongly support this correlation, especially when seen considering the specific initiatives, events, and developments of the Ayush sector which have been highlighted in a particular timeline by the Hon’ble PM, show a parallel upsurge in that specific (or related) sub-sector of Ayush. The objective of the current study is to Analyze & establish the impact of Ayush related highlights & mentions of the Hon’ble Prime Minister on ‘Mann Ki Baat’, on the Ayush sector. In the current work the Objective analysis of ongoing initiatives, events of Ministry of Ayush, supported by Ayush Strategic Policy & Facilitation Bureau (Invest India). Knowledge derived from/data sourced from the following: 1. Ayush Strategic Policy & Facilitation Bureau (Invest India) knowledge sources & investigations 2. Ayush Strategic Policy & Facilitation Bureau (Invest India) industry interaction & feedback 3. Internal assessments & data from Ministry of Ayush 4. Startup India/Department for Promotion of Industry &Internal Trade databases 5. RIS Report on “Ayush Sector in India: Prospects & Challenges” 6. RIS Report on “Ayush Exports: Regulatory Opportunities & Challenges in Key Markets” 7. Invest India (Strategic Investment Research Unit) Report on “Think Holistic Health, Think India” 8. All India Institute of Ayurveda knowledge sourcesObservations and developments captured from the above have been juxtaposed thematically with domain-specific announcements by Hon’ble Prime Minister through ‘Mann Ki Baat’ and impacts have been studied in short-term (between 6 months to 1 year of announcement/attention given to a particular theme in Ayush) and sustainable long-term trends that have henceforth developed in the sector (as evidenced by Govt. data and ‘Mann Ki Baat’ announcements, from 2014 to 2023)Evidences from the listed methods &sources suggest a strong direct correlation between specific instances of Hon’ble Prime Minister’s coverage and/or mention of Ayush in ‘Mann Ki Baat’ (specific instances in Annexure 1) and a sustainable upsurge in the related domain Wof Ayush. Moreover, the overall synergistic impact o","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116472418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Pathyadi Churna and Trikatu Churna in the management of Amavata (rheumatoid arthritis): Protocol for a comparative clinical study Pathyadi Churna和Trikatu Churna治疗Amavata(类风湿关节炎)的疗效:一项比较临床研究方案
Pub Date : 2023-04-01 DOI: 10.4103/jras.jras_164_22
D. Makhija, P. Borkar, Priti R Desai, Renu Singh, R. Singhal
BACKGROUND: Rheumatoid arthritis (RA) is a chronic, progressive, systemic autoimmune disease primarily affecting the synovial joints. Clinical symptoms of RA are similar to Amavata- a disease mentioned in Ayurveda. As per the Ayurveda classical texts, the formation and deposition of Ama (biotoxin) play a significant role in the pathogenesis of Amavata (RA). Hence, Deepana (appetite stimulant) & Ama-pachana (interventions that digest the biotoxins) can be first line of treatment for managing RA. Being Deepana and Pachana, Pathyadi Churna and Trikatu Churna can mitigate the Ama, prevent its genesis in the body, and thereby break down the pathogenesis of RA. Both formulations have anti-inflammatory and analgesic action which is supportive while treating RA. The present study will compare the efficacy of Pathyadi Churna and Trikatu Churna in managing RA. MATERIALS AND METHODS: It will be a randomized, parallel-group comparative trial with a sample size of 110 participants. Patients of any gender aged 18 to 65 years diagnosed with Rheumatoid arthritis based on American College of Rheumatology (ACR) 2010 criteria and presenting with Sama clinical features of Amavata will be enrolled in the study. Participants will be divided randomly into two groups. In group I, Pathyadi Churna, and Group II, Trikatu Churna will be administered in 3 gm and 1 gm, respectively, twice daily after food with lukewarm water for four weeks. The efficacy of the study interventions will be assessed through the changes in Disease Activity Score 28 (DAS28) and Ayurvedic disease-specific parameters from baseline. CONCLUSION: The study will help generate evidence regarding the efficacy of Pathyadi Churna and Trikatu Churna in managing RA.
背景:类风湿性关节炎(RA)是一种慢性、进行性、系统性自身免疫性疾病,主要影响滑膜关节。类风湿性关节炎的临床症状类似于阿育吠陀中提到的一种疾病——阿玛瓦塔。根据阿育吠陀经典文献,Ama(生物毒素)的形成和沉积在Amavata (RA)的发病机制中起着重要作用。因此,Deepana(食欲刺激剂)和Ama-pachana(消化生物毒素的干预措施)可以作为治疗类风湿性关节炎的一线治疗方法。作为Deepana和Pachana, Pathyadi Churna和Trikatu Churna可以减轻Ama,防止其在体内发生,从而打破RA的发病机制。两种配方都具有抗炎和镇痛作用,在治疗类风湿性关节炎时具有支持作用。本研究将比较Pathyadi Churna和Trikatu Churna治疗RA的疗效。材料和方法:这将是一项随机、平行组比较试验,样本量为110名参与者。根据美国风湿病学会(American College of Rheumatology, ACR) 2010标准诊断为类风湿关节炎的年龄在18至65岁之间的任何性别的患者,并呈现Amavata的Sama临床特征,都将被纳入研究。参与者将被随机分为两组。第一组为Pathyadi Churna,第二组为Trikatu Churna,分别为3克和1克,每天两次,餐后用温水给药,持续四周。研究干预措施的有效性将通过疾病活动评分28 (DAS28)和阿育吠陀疾病特异性参数的基线变化来评估。结论:本研究将有助于提供证据,证明百加地和Trikatu百加地治疗类风湿性关节炎的疗效。
{"title":"Efficacy of Pathyadi Churna and Trikatu Churna in the management of Amavata (rheumatoid arthritis): Protocol for a comparative clinical study","authors":"D. Makhija, P. Borkar, Priti R Desai, Renu Singh, R. Singhal","doi":"10.4103/jras.jras_164_22","DOIUrl":"https://doi.org/10.4103/jras.jras_164_22","url":null,"abstract":"BACKGROUND: Rheumatoid arthritis (RA) is a chronic, progressive, systemic autoimmune disease primarily affecting the synovial joints. Clinical symptoms of RA are similar to Amavata- a disease mentioned in Ayurveda. As per the Ayurveda classical texts, the formation and deposition of Ama (biotoxin) play a significant role in the pathogenesis of Amavata (RA). Hence, Deepana (appetite stimulant) & Ama-pachana (interventions that digest the biotoxins) can be first line of treatment for managing RA. Being Deepana and Pachana, Pathyadi Churna and Trikatu Churna can mitigate the Ama, prevent its genesis in the body, and thereby break down the pathogenesis of RA. Both formulations have anti-inflammatory and analgesic action which is supportive while treating RA. The present study will compare the efficacy of Pathyadi Churna and Trikatu Churna in managing RA. MATERIALS AND METHODS: It will be a randomized, parallel-group comparative trial with a sample size of 110 participants. Patients of any gender aged 18 to 65 years diagnosed with Rheumatoid arthritis based on American College of Rheumatology (ACR) 2010 criteria and presenting with Sama clinical features of Amavata will be enrolled in the study. Participants will be divided randomly into two groups. In group I, Pathyadi Churna, and Group II, Trikatu Churna will be administered in 3 gm and 1 gm, respectively, twice daily after food with lukewarm water for four weeks. The efficacy of the study interventions will be assessed through the changes in Disease Activity Score 28 (DAS28) and Ayurvedic disease-specific parameters from baseline. CONCLUSION: The study will help generate evidence regarding the efficacy of Pathyadi Churna and Trikatu Churna in managing RA.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124954420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety evaluation of Shatavari Gudam and Triphala Kashaya in leucorrhoea (Shwetapradara) – A study protocol of an open-label, multicenter, interventional, single-arm trial Shatavari Gudam和Triphala Kashaya治疗白带(Shwetapradara)的疗效和安全性评价——一项开放标签、多中心、介入性、单臂试验的研究方案
Pub Date : 2023-04-01 DOI: 10.4103/jras.jras_168_22
Savita Gopod, Sujata P. Dhoke, K. Anumol, P. Kumar, Soumya Sheji, Manisha Talekar, L. Sharma, Arunabh Tripathi, S. Ota
BACKGROUND: In the classical text of Ayurveda, formulations Shatavari Gudam (SG) and Triphala Kashaya (TK) are indicated to treat Shwetapradara. The disease Shwetapradara can be correlated to leucorrhoea based on the similar symptom, painless, white-colored discharge from the vagina. SG is a formulation containing Shatavari (Asparagus racemosus) as a main ingredient. Several studies indicate Shatavari as a tonic for reproductive tract-related diseases. The external use of Triphala has anti-inflammatory, antiseptic, and anti-bacterial actions. The present article is a clinical study protocol on the efficacy and safety evaluation of SG and TK in leucorrhoea (Shwetapradara). MATERIALS AND METHODS: It will be a multicenter, prospective single-arm study planned to be conducted at Regional Ayurveda Research Institute, Thiruvananthapuram, Regional Ayurveda Research Institute Nagpur, National Ayurveda Research Institute for Panchakarma, Cheruturthy and Regional Ayurveda Research Institute Vijayawada. One hundred sixty participants will be recruited for the trial (40 from each center). In the dose of 6gm, SG will be administered twice daily with lukewarm water after food. Vaginal douche will be done with TK for seven days in two consecutive cycles. The primary outcome will be change in the quantity of white discharge using visual analog scale. The secondary outcome will be change in other associated symptoms like pruritis vulva, lower abdominal pain, low back ache, burning micturition, and dyspareunia using the Visual Analogue Scale; change in the Quality of life and well-being by PGWBI score; change in Score of Investigator’s Global Satisfaction Scale, and changes in Patient’s Global Satisfaction Scale from baseline to final visit. Clinical/biochemical assessments will determine the safety and tolerability of the formulation during the follow-ups. Compared with the baseline, the efficacy of interventions on the 84th and 98th day, will be assessed with Paired t-test. Data will be analyzed using SPSS 15.0 software. ETHICS AND DISSEMINATION: The IEC clearance has been obtained from each participating institute. After completion of the trial, the outcome will be disseminated through peer-reviewed journals for publication.
背景:在阿育吠陀经典文献中,沙塔瓦里古达姆(SG)和Triphala Kashaya (TK)方用于治疗湿婆达拉达拉。基于相似的症状,无痛,阴道排出白色分泌物,可将该病与白带联系起来。SG是一种以总状芦笋为主要成分的制剂。几项研究表明,沙塔瓦里是一种补品,用于生殖道相关疾病。外用Triphala具有消炎、杀菌、抗菌的作用。本文是SG和TK治疗白带(Shwetapradara)疗效和安全性评价的临床研究方案。材料和方法:这将是一项多中心、前瞻性单臂研究,计划在蒂鲁凡南塔普拉姆地区阿育吠陀研究所、那格浦尔地区阿育吠陀研究所、Panchakarma国家阿育吠陀研究所、Cheruturthy和维杰亚瓦达地区阿育吠陀研究所进行。该试验将招募160名参与者(每个中心40名)。SG每日2次,剂量为6gm,餐后用温水给药。阴道灌洗将在连续两个周期中用TK进行七天。主要结果将是使用视觉模拟量表的白色放电量的变化。次要结局将是其他相关症状的改变,如外阴瘙痒、下腹痛、腰痛、排尿灼痛和性交困难(使用视觉模拟量表);PGWBI评分对生活质量和幸福感的影响;研究者总体满意度量表得分的变化,以及患者总体满意度量表从基线到最后一次就诊的变化。临床/生化评估将在随访期间确定该制剂的安全性和耐受性。与基线比较,干预措施在第84天和第98天的疗效将采用配对t检验进行评估。数据将使用SPSS 15.0软件进行分析。伦理和传播:已获得各参与研究所的IEC许可。试验完成后,结果将通过同行评议的期刊发布。
{"title":"Efficacy and safety evaluation of Shatavari Gudam and Triphala Kashaya in leucorrhoea (Shwetapradara) – A study protocol of an open-label, multicenter, interventional, single-arm trial","authors":"Savita Gopod, Sujata P. Dhoke, K. Anumol, P. Kumar, Soumya Sheji, Manisha Talekar, L. Sharma, Arunabh Tripathi, S. Ota","doi":"10.4103/jras.jras_168_22","DOIUrl":"https://doi.org/10.4103/jras.jras_168_22","url":null,"abstract":"BACKGROUND: In the classical text of Ayurveda, formulations Shatavari Gudam (SG) and Triphala Kashaya (TK) are indicated to treat Shwetapradara. The disease Shwetapradara can be correlated to leucorrhoea based on the similar symptom, painless, white-colored discharge from the vagina. SG is a formulation containing Shatavari (Asparagus racemosus) as a main ingredient. Several studies indicate Shatavari as a tonic for reproductive tract-related diseases. The external use of Triphala has anti-inflammatory, antiseptic, and anti-bacterial actions. The present article is a clinical study protocol on the efficacy and safety evaluation of SG and TK in leucorrhoea (Shwetapradara). MATERIALS AND METHODS: It will be a multicenter, prospective single-arm study planned to be conducted at Regional Ayurveda Research Institute, Thiruvananthapuram, Regional Ayurveda Research Institute Nagpur, National Ayurveda Research Institute for Panchakarma, Cheruturthy and Regional Ayurveda Research Institute Vijayawada. One hundred sixty participants will be recruited for the trial (40 from each center). In the dose of 6gm, SG will be administered twice daily with lukewarm water after food. Vaginal douche will be done with TK for seven days in two consecutive cycles. The primary outcome will be change in the quantity of white discharge using visual analog scale. The secondary outcome will be change in other associated symptoms like pruritis vulva, lower abdominal pain, low back ache, burning micturition, and dyspareunia using the Visual Analogue Scale; change in the Quality of life and well-being by PGWBI score; change in Score of Investigator’s Global Satisfaction Scale, and changes in Patient’s Global Satisfaction Scale from baseline to final visit. Clinical/biochemical assessments will determine the safety and tolerability of the formulation during the follow-ups. Compared with the baseline, the efficacy of interventions on the 84th and 98th day, will be assessed with Paired t-test. Data will be analyzed using SPSS 15.0 software. ETHICS AND DISSEMINATION: The IEC clearance has been obtained from each participating institute. After completion of the trial, the outcome will be disseminated through peer-reviewed journals for publication.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131001131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mann Ki Baat Inspiration: Reimagining India’s health system 灵感:重新构想印度的卫生系统
Pub Date : 2023-04-01 DOI: 10.4103/jras.jras_98_23
B. Patwardhan
{"title":"Mann Ki Baat Inspiration: Reimagining India’s health system","authors":"B. Patwardhan","doi":"10.4103/jras.jras_98_23","DOIUrl":"https://doi.org/10.4103/jras.jras_98_23","url":null,"abstract":"","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130644597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research initiatives and network linkages in COVID-19: Neo-dynamics of R&D in the Ayush sector 2019冠状病毒病的研究举措和网络联系:阿尤什行业研发的新动态
Pub Date : 2023-04-01 DOI: 10.4103/jras.jras_77_23
Narayanam Srikanth, Sophia Jameela, A. Rai, B. Rao, S. Khanduri, B. Yadav
{"title":"Research initiatives and network linkages in COVID-19: Neo-dynamics of R&D in the Ayush sector","authors":"Narayanam Srikanth, Sophia Jameela, A. Rai, B. Rao, S. Khanduri, B. Yadav","doi":"10.4103/jras.jras_77_23","DOIUrl":"https://doi.org/10.4103/jras.jras_77_23","url":null,"abstract":"","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"51 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129972944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrative medicine: A unified approach for the future medicine 结合医学:未来医学的统一方法
Pub Date : 2023-01-01 DOI: 10.4103/jras.jras_154_22
Abhimanyu Kumar
In India, various healthcare systems are practiced, and every system is well-received by its citizens. Recently, the Government of India has planned to develop a “One Nation, One Health System” to offer a unified Health Care System with all the possible advantages of every system of medicine. Regarding such a plan, a well-designed Integrative Medicine Protocol for various diseases is the need of the hour. This approach to health care should be implemented after a thorough review of the situation, which may come across as a hurdle. A single healthcare system will allow for better outcomes and potentially improve the country’s quality of health care.
在印度,实行各种各样的医疗保健制度,每一种制度都受到公民的欢迎。最近,印度政府计划发展“一个国家,一个卫生系统”,以提供一个统一的卫生保健系统,其中包括每种医学系统的所有可能的优势。对于这样一个计划,一个精心设计的针对各种疾病的综合医学方案是当务之急。这种保健方法应该在对情况进行彻底审查之后实施,这可能会成为一个障碍。单一的医疗保健系统将带来更好的结果,并有可能提高该国的医疗保健质量。
{"title":"Integrative medicine: A unified approach for the future medicine","authors":"Abhimanyu Kumar","doi":"10.4103/jras.jras_154_22","DOIUrl":"https://doi.org/10.4103/jras.jras_154_22","url":null,"abstract":"In India, various healthcare systems are practiced, and every system is well-received by its citizens. Recently, the Government of India has planned to develop a “One Nation, One Health System” to offer a unified Health Care System with all the possible advantages of every system of medicine. Regarding such a plan, a well-designed Integrative Medicine Protocol for various diseases is the need of the hour. This approach to health care should be implemented after a thorough review of the situation, which may come across as a hurdle. A single healthcare system will allow for better outcomes and potentially improve the country’s quality of health care.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"97 3-4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132193377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One Nation, One Health System integrative policy: Blending wisdom of ancient and contemporary health sciences “一国一卫”一体化政策:融合古今卫生科学智慧
Pub Date : 2023-01-01 DOI: 10.4103/jras.jras_148_22
C. Katiyar, Sunil Dubey
Convergence of Ayush/traditional medicines with modern medicines by bringing into effect integration of the two or more systems is the way forward for developing holistic healthcare systems throughout the country, based on the concept of the One Nation, One Health System. Adopting schemes, programs, and strategies for bringing about changes in the education system and medical practice, along with ensuring their implementation at each stratum, will aid in unifying the healthcare systems. Given the existence of medical pluralism in India, it is the need of the hour to amalgamate our ancient traditional knowledge and contemporary medicine to build a system wherein both work in unison to promote good health and confer protection from various diseases and make provision for their management in the best possible manner. The current article discusses the requirements and probable impact of developing such system.
通过整合两种或两种以上的系统,将阿尤什/传统药物与现代药物结合起来,是在“一国一卫生系统”的概念基础上,在全国范围内发展整体医疗保健系统的前进方向。采用改革教育系统和医疗实践的方案、方案和战略,并确保在每个阶层实施,将有助于统一医疗保健系统。鉴于印度医疗多元化的存在,当务之急是将我们古老的传统知识和现代医学结合起来,建立一个系统,使两者协同工作,促进身体健康,保护人们免受各种疾病的侵害,并以最好的方式为他们提供管理。本文讨论了开发这种系统的要求和可能产生的影响。
{"title":"One Nation, One Health System integrative policy: Blending wisdom of ancient and contemporary health sciences","authors":"C. Katiyar, Sunil Dubey","doi":"10.4103/jras.jras_148_22","DOIUrl":"https://doi.org/10.4103/jras.jras_148_22","url":null,"abstract":"Convergence of Ayush/traditional medicines with modern medicines by bringing into effect integration of the two or more systems is the way forward for developing holistic healthcare systems throughout the country, based on the concept of the One Nation, One Health System. Adopting schemes, programs, and strategies for bringing about changes in the education system and medical practice, along with ensuring their implementation at each stratum, will aid in unifying the healthcare systems. Given the existence of medical pluralism in India, it is the need of the hour to amalgamate our ancient traditional knowledge and contemporary medicine to build a system wherein both work in unison to promote good health and confer protection from various diseases and make provision for their management in the best possible manner. The current article discusses the requirements and probable impact of developing such system.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130167032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aligning collaboration and integration towards “One Nation, One Health System” for a resilient public health delivery 协调协作和一体化,实现“一国一卫生系统”,以提供有弹性的公共卫生服务
Pub Date : 2023-01-01 DOI: 10.4103/jras.jras_177_22
V. Kotecha
{"title":"Aligning collaboration and integration towards “One Nation, One Health System” for a resilient public health delivery","authors":"V. Kotecha","doi":"10.4103/jras.jras_177_22","DOIUrl":"https://doi.org/10.4103/jras.jras_177_22","url":null,"abstract":"","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"231 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122773072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integration of Ayush within national health care systems: Challenges and the way forward 阿尤什在国家卫生保健系统中的整合:挑战和前进的道路
Pub Date : 2023-01-01 DOI: 10.4103/jras.jras_166_22
SP Thyagarajan
The utilization of traditional knowledge is crucial for achieving universal healthcare, according to the World Health Organization (WHO) Traditional Medicine Strategy 2014–23. The Indian systems of Medicine—Ayurveda, Yoga, Unani, Siddha, and homeopathy (Ayush)—have been projected to play a significant role in universal healthcare due to the emphasis placed on preventive and promotive health, their reasonable cost, low level of technological input, and the rising popularity of naturally derived plant-based products. These systems are being recommended for inclusion in national public health policy. Traditional Medicine (TM) is being used more frequently, which has raised questions regarding its safety and toxicity potential, such as hepatotoxicity. Thus, under the Department of Ayush’s vision and mission-2030, it is intended to develop scientific evidence in Ayurvedic principles and drug therapies by integrating ancient wisdom with modern technology and to bring Ayurveda to the people through innovations related to diagnostics, preventive, promotive as well as treatment methods and introduce scientific research for sustained availability of quality natural resources, to translate them into practical applications as modern science solutions for ensuring international acceptance of Ayush systems and their integration into National Health System and Modern Medicine, achieving the goal of One Nation, One Health System. Ayurvedic biology, standardization through chemobiological fingerprinting, chemobiological assays, and Pharmacovigilance studies of herbal medicines are suggested.
根据世界卫生组织(世卫组织)《2014-23年传统医学战略》,利用传统知识对于实现全民医疗保健至关重要。印度的医学体系——阿育吠陀、瑜伽、乌纳尼、悉达陀和顺势疗法(阿尤什)——由于强调预防和促进健康,成本合理,技术投入水平低,以及天然植物性产品的日益普及,预计将在全民医疗保健中发挥重要作用。正在建议将这些系统纳入国家公共卫生政策。传统医学(TM)的使用越来越频繁,这引发了对其安全性和潜在毒性(如肝毒性)的质疑。因此,根据阿尤什部门的愿景和使命-2030,它旨在通过将古代智慧与现代技术相结合,开发阿育吠陀原理和药物治疗的科学证据,并通过与诊断,预防,促进和治疗方法相关的创新,将阿育吠陀带给人们,并引入科学研究,以持续获得优质自然资源。将其转化为实际应用,作为现代科学解决方案,确保国际接受阿尤什系统并将其纳入国家卫生系统和现代医学,实现“一国一卫生系统”的目标。建议通过化学生物指纹、化学生物分析和草药药物警戒研究来标准化阿育吠陀生物学。
{"title":"Integration of Ayush within national health care systems: Challenges and the way forward","authors":"SP Thyagarajan","doi":"10.4103/jras.jras_166_22","DOIUrl":"https://doi.org/10.4103/jras.jras_166_22","url":null,"abstract":"The utilization of traditional knowledge is crucial for achieving universal healthcare, according to the World Health Organization (WHO) Traditional Medicine Strategy 2014–23. The Indian systems of Medicine—Ayurveda, Yoga, Unani, Siddha, and homeopathy (Ayush)—have been projected to play a significant role in universal healthcare due to the emphasis placed on preventive and promotive health, their reasonable cost, low level of technological input, and the rising popularity of naturally derived plant-based products. These systems are being recommended for inclusion in national public health policy. Traditional Medicine (TM) is being used more frequently, which has raised questions regarding its safety and toxicity potential, such as hepatotoxicity. Thus, under the Department of Ayush’s vision and mission-2030, it is intended to develop scientific evidence in Ayurvedic principles and drug therapies by integrating ancient wisdom with modern technology and to bring Ayurveda to the people through innovations related to diagnostics, preventive, promotive as well as treatment methods and introduce scientific research for sustained availability of quality natural resources, to translate them into practical applications as modern science solutions for ensuring international acceptance of Ayush systems and their integration into National Health System and Modern Medicine, achieving the goal of One Nation, One Health System. Ayurvedic biology, standardization through chemobiological fingerprinting, chemobiological assays, and Pharmacovigilance studies of herbal medicines are suggested.","PeriodicalId":394246,"journal":{"name":"Journal of Research in Ayurvedic Sciences","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126006155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Research in Ayurvedic Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1